AOD9604: 5mg x10 Vials

AOD9604 is a modified fragment of human growth hormone (hGH 177–191) studied in Australian preclinical research for its role in lipid metabolism and adipose tissue regulation. Australian laboratories investigate fat oxidation pathways, metabolic rate modulation, and cellular energy homeostasis: without the growth-promoting effects of full-length hGH: in controlled metabolic research models.

No. AOD9604 is strictly for laboratory research only. It is not intended for human consumption, weight management, therapeutic application, or diagnostic use. Australian researchers must confirm legitimate research intent.

Refer to product documentation for specific storage guidance. In general, store lyophilised AOD9604 in a freezer. After reconstitution with bacteriostatic water, refrigerate and follow the usage timeframe in the product documentation. Protect vials from light, moisture, and temperature fluctuation. Follow aseptic procedures in a controlled laboratory setting.

Availability varies by product and batch. Where independent testing is complete, batch-specific Certificates of Analysis are available on request.

AOD9604 is dispatched within 1–3 business days from our international fulfilment partners in temperature-protected packaging. Estimated delivery is 5–9 days from order, processing included, express with a carrier tracking number. Free shipping on orders over $700 AUD express with a carrier tracking number. Trial vials are faster: they ship from domestic stock via Australia Post Express, same-day dispatch before 3 PM AEST, arriving in 2–3 business days.